This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

按主题浏览我们的活动，培训，文章和人员关

Popular sectors

A - Z.

浏览主题 应用 关
搜索

Partnering, Business Development & Licensing

影响生命科学行业业务战略的人民的活动，新闻和信息。

Articles & Video

Showing 22 of 343 articles & video
PARTNERING INSIGHT: Timely News for Life Science Dealmakers
Featured
BIO-Europe 2020

Biopharma合金博宝188备用地址作和融资趋势，H1 2020

在Biomedtracker的帮助下，Pharma智能的分析师在2019年至2020年的第一个半年期间深入了解全球Biopharma产业伙伴关系和金融发布。他们发现的是令人惊讶和新的白皮书内。
Featured
BioPharm America™ 2020

生物技术启动：如何在Covid-19世界中取得成功

通过临床试验从概念中获取生物技术公司，最终向市场上市需要一个完美的良好科学风暴，健全的投资和正确的管理。此电子书在此用于通过此旅程指导初创公司。
ChinaBio Partnering Forum 2020

Interview: Promoting prosperity in the life science sectors of China and the UK

在这次独家采访中，她的陛下对国际贸易部的贸易专员John Edwards，讨论了中国的医疗保健和生命科学市场如何迅速增长，并通过增加需求和对法规的变化而导致的。
ChinaBio Partnering Forum 2020

Interview: Importance of diversity and partnering in global life sciences

ATLATL Innovation Cluster (IC) in the heart of Zhangjiang Pharma Valley. Its Founder and CEO, Dr. P.C. Zhu, designed it to be a launchpad for high-potential life sciences in China. In this interview with EBD Group he discusses the opportunities ATLATL provides and the importance of partnering in the life science industry.
ChinaBio Partnering Forum 2020

视频访谈 - 约翰逊＆约翰逊的外部创新方法

William N. Hait, MD, PhD, Global Head at Johnson & Johnson External Innovation gives an exclusive interview to Lucie Ellis, Executive Editor of In Vivo, Pharma Intelligence, ahead of ChinaBio® Partnering Forum Digital.
ChinaBio Partnering Forum 2020

Interview – J&J’s multi-pronged approach to life science innovation, partnerships, and advanced technologies

Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the importance of collaborations and much more in this exclusive interview with EBD Group.
Biopharma

SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic

We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
ChinaBio Partnering Forum 2020

报告：中国州生命科学 - 2020 H1

Download this new exclusive ChinaBio® report with in-depth analysis of investment and partnering activity in China for 2020 H1 to discover the factors driving China life science investment. Learn how VC, IPO, and Partnering have rebounded despite COVID-19, but how M&A continues to slump.
ChinaBio Partnering Forum 2020

热门生物技术在中国优惠

发现转型中国生物技术的交易！在今年在中国迄今为止已经产生了超过120亿美元的生物摩托车融资，联盟，IPO和新资金。当您阅读此新的免费信息图表时，了解这些交易的详细信息。
Drug Development

Pharma R&D Annual Review 2020

Pharma Intelligence的研究人员和分析师已经猜测了在过去几年中如何进出药物研究和发展以及2020年的预期。Pharma研发年度审查2020融入了对开发中所有药物的彻底分析由制药公司，从临床前阶段的那些，通过各种阶段的临床测试和监管批准，并达到和包括发射。
Drug Development

中国科迪德 - 19的挑战和机遇

探索中国的药物公司如何合作，从未以前从未遵循过供应链，并要求政府帮助解决公共卫生危机的必要问题。
ChinaBio Partnering Forum 2020

采访罗氏的药物发现，创新和满足患者需求的方法

罗氏制药合伙人詹姆斯·萨布里讨论了罗氏的发现科学突破，加速了创新研究，与利益相关者金博宝188备用地址合作，并在中国和世界各地满足未满足的医疗需求。
革新

Biopharma和Tech Innovators - 2020年夏季

下载Xconomy和EBD集团的新特别报告，Biopharma和Tech Innovators - 2020年夏季，了解有关这些创新背后的尖端公司的更多信息，这些公司正在扰乱该部门并彻底改变医疗保健景观。
革新

最新的癌症发展和趋势

Discover the latest trends and advancements in cancer treatment in this new article pack from Informa Pharma Intelligence. Inside this downloadable article pack you will discover what is driving oncology dealmaking in 2020.
BIO-Europe Spring

通过创新和投资含有冠状病毒：Xconomy特别报告

本报告包含一些主要参与者的想法，创新和经验，这些主要参与者在打击Covid-19的最前沿。独家文章被Bio-EuropeSpring®活动捕获，并附有来自B2B出版物Xconomy和BioProcess Insider的一些最相关的故事。
BIO-Europe Spring

Roche最近合作的后台视图

In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
BIO-Europe Spring

肿瘤学需要组合治疗和更多数据分析，说生物欧洲春天面板

癌症护理的未来改善最有可能源于组合疗法和数据驱动的预防努力以及突破性药物。这是本周在网络广播中共享的留言生命科学专家，就生物欧洲春季合作会议记录了“未来十年的下一十年”主题。金博宝188备用地址
BIO-Europe Spring

Servier世界先导:一个全球创新引擎to boost early-stage R&D through partnering

In today’s rapidly changing and ever-evolving global biomedical innovation ecosystem, collaboration and partnerships are key to R&D success to ensure the development of a sustainable pipeline of innovative new medicines.
Drug Development

New approaches to drug discovery and development enabled by platform success

相对较小的支持技术平台公司正在改变患者的未来，药物发现科学家，治疗科学家，开发商，新治疗方法科学家加上付款人。有时，重要的是提醒自己，生物技术正在为全球医疗行业的利益工作，而不仅仅是我们当地的市场。
BIO-Europe Spring

The 2020 Outlook for Europe

Discover insights and gain helpful advice in this curated article pack from Informa Pharma Intelligence on biotech, regulations, pharma, and financial investment in Europe and the United Kingdom.
生物肺刺植物

巴黎地区领导地区的个性化医学和生物野蛮3.0

Medicen Paris Region is thrilled to host the 2020 edition of BIO-Europe Spring following the great success of the 2015 conference here. The Paris Region is a worldwide hub when it comes to healthcare innovation, and the very first European region when it comes to biopharma specifically. It is indeed home to 1,000+ life sciences startups, more than 1,200 public and private R&D labs and 12,000 life sciences researchers, and Europe’s largest hospital network.
Biotech showcase™2020

PharmAI – Industry is Smartening Up to Potential of Artificial Intelligence

人工智能（AI）在改变医疗保健和改善患者结果的情况下具有巨大潜力，在模式检测，患者监测，疾病诊断和治疗选择中的应用。理由是AI可用于增强决策过程，考虑到远远超过通过常规手段的医生可用的数据。

Copyright ©2020金宝搏App下载